运动负荷心肌灌注显像中血流动力学增益指数的增量预后价值
这项双中心回顾性队列纳入1254例接受运动SPECT-MPI的可疑或已知冠心病患者,中位随访63个月,187例(14.9%)发生MACE。HGI与负荷TPD相关性可忽略,HGI每增加1个SD与MACE风险降低相关,且将HGI加入含负荷TPD的模型可改善模型拟合、C-index和连续NRI;在负荷TPD<5%的患者中,高HGI组5年无MACE生存率高于低HGI组。
要点
- HGI与负荷TPD相关性可忽略,提供互补的预后信息。
- HGI每增加1个SD,MACE风险比为0.748(95%CI 0.623-0.898,P=0.002)。
- 负荷TPD<5%时,高HGI组5年无MACE生存率92.1%,低HGI组80.1%。
核心结论
- HGI在负荷灌注显像之外提供独立且增量的预后信息,并可对负荷TPD<5%的患者进行长期风险分层。
研究设计与样本
- 双中心回顾性队列纳入1254例接受运动SPECT-MPI的可疑或已知冠心病患者,中位随访63个月。
主要发现
- 随访期间187例(14.9%)发生MACE。
- HGI与负荷TPD相关性可忽略(ρ=0.012,P=0.675)。
- HGI每增加1个SD与MACE风险降低相关(HR 0.748,95%CI 0.623-0.898,P=0.002)。
- 将HGI加入含负荷TPD的模型改善模型拟合(Δχ2=9.71,P=0.002)、C-index(ΔC-index=0.006,P=0.046)和连续NRI(0.310,P=0.010)。
- 负荷TPD<5%患者中,高HGI组5年无MACE生存率92.1%,低HGI组80.1%。
关键数值与推荐
- HGI由静息至峰值运动的率压乘积相对增加推导。
- 主要终点MACE包括全因死亡、非致死性心肌梗死、不稳定型心绞痛住院和晚期血运重建。
- 增量判别在24个月时变得显著,60个月时最大。
临床怎么用
- 在运动SPECT-MPI报告中可考虑结合HGI对负荷TPD<5%的患者进一步风险分层。
- HGI与灌注指标互补,可能有助于识别残余风险较高的患者。
局限性
- HGI在接受心血管活性药物治疗患者中的预后表现尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Normal exercise single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) findings are associated with a favorable prognosis, but residual risk remains heterogeneous. The hemodynamic gain index (HGI), derived from the relative increase in rate-pressure product from rest to peak exercise, may provide complementary prognostic information. METHODS: This dual-center retrospective cohort included 1254 patients with suspected or known coronary artery disease undergoing exercise SPECT-MPI. The primary endpoint was major adverse cardiovascular events (MACE), comprising all-cause death, nonfatal myocardial infarction, hospitalization for unstable angina, and late revascularization. A secondary endpoint excluded unstable angina. Mixed-effects Cox models assessed independent and incremental prognostic value. RESULTS: During a median follow-up of 63 months, 187 patients (14.9%) experienced MACE. HGI showed negligible correlation with stress total perfusion deficit (TPD) (ρ = 0.012, P = 0.675). Each 1-SD increase in HGI was associated with a lower MACE hazard (HR, 0.748; 95% CI, 0.623-0.898; P = 0.002). Adding HGI to a model containing stress TPD improved model fit (Δχ2 = 9.71, P = 0.002), C-index (ΔC-index = 0.006, P = 0.046), and continuous net reclassification improvement (0.310, P = 0.010). Among patients with stress TPD less than 5%, 5-year MACE-free survival was 92.1% with high HGI and 80.1% with low HGI. Incremental discrimination became significant at 24 months and was greatest at 60 months. CONCLUSIONS: HGI provided independent and incremental prognostic information beyond stress perfusion imaging and stratified longer-term risk among patients with stress TPD less than 5%. Its prognostic performance in patients receiving cardioactive medications requires further validation.
引用
- Yang S, Ma R, Xie W, et al. Incremental prognostic value of the hemodynamic gain index in patients undergoing exercise stress myocardial perfusion imaging. J Nucl Cardiol. 2026. PMID: 42471137. doi:10.1016/j.nuclcard.2026.102822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。